Antibiotic Guidelines

Chapter 11: Infective Endocarditis

Antibiotic Guidelines
Chapter 11: Infective Endocarditis
Read Document

Causes of Infective Endocarditis

By Valve Type:

                                                                                                               
Valve TypeMost Common CausesLess Common
Native ValveViridans streptococci (~50–70%)
Staphylococcus aureus (~25%)
Enterococci (~10%)
Gram-positive/negative bacilli
HACEK group
Fungi
Early Prosthetic ValveS. epidermidis
S. aureus
Late Prosthetic ValveViridans streptococci
S. aureus
Enterococci

Risk Factors

  • Cardiac: prior IE, prosthetic valve/device, valvular or congenital heart disease
  • Non-cardiac: IV drug use, indwelling IV lines, immunosuppression, recent procedures

Diagnosis

  • Use modified Duke criteria
  • Always obtain 3 sets of blood cultures (before antibiotics)
  • Echocardiography (TTE or TEE)
  • Other tests: ECG, CXR, serologies (if blood culture negative), valve PCR

Rare Causes: Suggested Lab Tests

                                                                                                                                                                       
PathogenRecommended Testing
Brucella spp.Blood cultures, serology, valve histology, PCR
Coxiella burnetiiSerology, valve culture/PCR
Bartonella spp.Blood cultures, serology, valve histology, PCR
Tropheryma whippleiValve histology + PCR
Mycoplasma spp.Serology, culture, valve PCR
Legionella spp.Serology, culture, valve PCR
FungiBlood cultures, valve fungal PCR

Empiric Therapy

NVE (Indolent):

  • Ampicillin 2 g IV q4h + Gentamicin 3 mg/kg IV daily

NVE (Severe, no Gram-negative risk):

  • Vancomycin 1 g IV q12h + Gentamicin 3 mg/kg IV daily

NVE (Severe, MDR risk):

  • Vancomycin 1 g IV q12h + Meropenem 2 g IV q8h

PVE or Blood Culture Negative:

  • Vancomycin + Gentamicin + Rifampicin

Staphylococcal Endocarditis

                                                                                                                                         
TypeDrugsDuration (weeks)
NVE (MSSA)Flucloxacillin 2 g IV q4–6h4
NVE (MRSA or allergy)Vancomycin 1 g IV q12h + Rifampicin 300–600 mg PO q12h4
PVE (MSSA)Flucloxacillin + Rifampicin + Gentamicin6 each
PVE (MRSA or allergy)Vancomycin + Rifampicin + Gentamicin6 + 6 + 2+

Streptococcal Endocarditis

Treatment depends on MIC:

  • MIC ≤ 0.125 mg/L:
    • Penicillin 1.2 g IV q4h OR Ceftriaxone 2 g daily
    • Add Gentamicin for 2 weeks if synergy needed
  • MIC > 0.125–0.5 mg/L:
    • Penicillin 2.4 g IV q4h + Gentamicin 3 mg/kg IV daily × 4–6 weeks

Enterococcal Endocarditis

  • Ampicillin-susceptible:
    • Ampicillin + Gentamicin OR Penicillin + Gentamicin × 4–6 weeks
  • Penicillin-resistant or allergy:
    • Vancomycin + Gentamicin × 4–6 weeks
  • Alternative:
    • Teicoplanin + Gentamicin

Blood Culture–Negative Endocarditis (Empiric)

                                                                                                               
CauseRegimenDuration
BrucellaDoxycycline + Cotrimoxazole + Rifampicin≥3 weeks
BartonellaAmpicillin + Gentamicin OR Doxycycline + Gentamicin6 weeks
Coxiella burnetiiDoxycycline + Hydroxychloroquine OR Ciprofloxacin≥18 months

HACEK Endocarditis

                                               
RegimenDuration
Ceftriaxone + Gentamicin OR Ampicillin + Gentamicin4 weeks

Fungal Endocarditis

Candida

  • Initial: echinocandin or liposomal amphotericin B
  • Surgical valve replacement usually required
  • Treat ≥6 weeks post-surgery
  • Long-term suppressive antifungal therapy may be needed

Aspergillus

  • Voriconazole IV with monitoring
  • Surgery essential
  • Duration: ≥6 weeks, followed by maintenance therapy